非酒精相关肝硬化急性静脉曲张出血后6周死亡率高于酒精相关肝硬化
该研究基于美国(n=469)和新加坡(n=880)两个大型多中心队列共1349例急性静脉曲张出血(AVB)肝硬化患者,比较酒精相关肝病(ALD)与非酒精相关肝病(non-ALD)肝硬化的6周死亡率。校正CTP、MELD或MELD 3.0评分后,non-ALD肝硬化的6周死亡率显著高于ALD肝硬化(aOR分别为2.9、3.0、3.3)。将病因加入现有预后评分可改善6周死亡率预测(MELD 3.0 c-statistic 0.784 vs 0.770,P < .001),病因校正的更新MELD 3.0模型预测最佳。
要点
- 在1349例AVB肝硬化患者中,non-ALD肝硬化校正CTP评分后6周死亡率显著高于ALD肝硬化(aOR 2.9)。
- 校正MELD评分后aOR为3.0,校正MELD 3.0评分后aOR为3.3,均显示non-ALD风险更高。
- 加入病因(ALD vs non-ALD)后MELD 3.0预测6周死亡率改善(c-statistic 0.784 vs 0.770,P < .001)。
核心结论
- non-ALD肝硬化患者发生AVB后6周死亡风险高于ALD肝硬化患者,且在校正标准肝病严重程度指标后各严重程度层面均如此。
- 作者认为应将肝硬化病因(ALD vs non-ALD)纳入AVB患者的风险分层。
研究设计与样本
- 研究评估美国(n=469)和新加坡(n=880)两个大型多中心队列中肝硬化合并AVB患者出血后结局,共纳入1349例。
- 采用多变量logistic回归比较ALD与non-ALD肝硬化的6周死亡率,并对总队列进行倾向性评分匹配敏感性分析。
主要发现
- 总队列中ALD肝硬化379例(27.5%),总体6周死亡率为14.4%。
- 校正CTP评分后,non-ALD肝硬化6周死亡率显著高于ALD肝硬化(aOR 2.9;95%CI 1.5-5.3)。
- 校正MELD评分后aOR为3.0(95%CI 1.6-5.6),校正MELD 3.0评分后aOR为3.3(95%CI 1.7-6.4)。
- 将病因加入现有预后评分改善6周死亡率预测(MELD 3.0 c-statistic 0.784 vs 0.770;P < .001)。
- 病因校正的更新MELD 3.0模型是AVB后6周死亡率的最佳预测模型。
关键数值与推荐
- non-ALD肝硬化校正CTP评分后6周死亡率高于ALD肝硬化(aOR 2.9;95%CI 1.5-5.3)。
- non-ALD肝硬化校正MELD评分后6周死亡率高于ALD肝硬化(aOR 3.0;95%CI 1.6-5.6)。
- non-ALD肝硬化校正MELD 3.0评分后6周死亡率高于ALD肝硬化(aOR 3.3;95%CI 1.7-6.4)。
- 加入病因后MELD 3.0预测6周死亡率改善(c-statistic 0.784 vs 0.770;P < .001)。
临床怎么用
- 作者认为应将肝硬化病因(ALD vs non-ALD)纳入AVB患者的风险分层。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute variceal bleeding (AVB) portends significant 6-week mortality in patients with cirrhosis. It remains unclear if the correlation between liver prognostic scores and 6-week mortality are similar across different etiologies of liver cirrhosis, particularly alcohol-related liver disease (ALD) vs non-alcohol-related liver disease (non-ALD). This study aims to compare the 6-week mortality following AVB in these 2 patient populations. METHODS: We assessed outcomes after AVB in 2 large multicenter cohorts from the United States and Singapore of patients with cirrhosis presenting with AVB. Using multivariable logistic regression, 6-week mortality between ALD and non-ALD cirrhosis was compared. Sensitivity analyses were performed with propensity-score matching analyses of the overall cohort. RESULTS: A total of 1349 patients with AVB from the United States (n = 469) and Singapore (n = 880) cohorts were included. The aggregated cohort consisted of 379 patients (27.5%) with ALD cirrhosis. The overall 6-week mortality was 14.4%. Non-ALD cirrhosis was associated with a significantly higher 6-week mortality than ALD cirrhosis after accounting for Child-Turcotte-Pugh (CTP) score (adjusted odds ratio [aOR], 2.9; 95% confidence interval [CI], 1.5-5.3), Model of End-stage Liver Disease (MELD) score (aOR, 3.0; 95% CI, 1.6-5.6), and MELD 3.0 score (aOR, 3.3; 95% CI, 1.7-6.4). Addition of cirrhosis etiology (ALD vs non-ALD) to existing prognostic scores improved the prediction of 6-week mortality following AVB (MELD 3.0 c-statistic: 0.784 vs 0.770; P < .001). An etiology-adjusted updated MELD 3.0 model was the best prediction model for 6-week mortality after AVB. CONCLUSION: Patients with non-ALD cirrhosis presenting with AVB had a higher risk of 6-week mortality, at each severity of liver disease by standard indices, than patients with ALD cirrhosis. Cirrhosis etiology (ALD vs non-ALD) should be incorporated into the risk stratification of patients with AVB.
引用
- Wong YJ, Buckholz A, Sim A, et al. Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis. Clin Gastroenterol Hepatol. 2024. PMID: 39675401. doi:10.1016/j.cgh.2024.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。